Distinct vasodilation, without reflex neurohormonal activation, induced by barnidipine in hypertensive patients

Blood Pressure, Supplement

Volumn 7, Issue , 1998, Pages 9-14

  Argenziano, L ^a   Izzo, R ^a   Iovino, G ^a   De Luca, N ^a   Parrella, L ^a   Morisco, C ^a   Trimarco, B ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Adrenergic agents; Barnidipine; Calcium antagonist; Hormones; Nitrendipine; Noradrenaline; Sympathetic nervous system

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; MEPIRODIPINE; NITRENDIPINE; NORADRENALIN; ANTIHYPERTENSIVE AGENT; DRUG DERIVATIVE; NIFEDIPINE;

ADRENERGIC STIMULATION; ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STANDING; SUPINE POSITION; TREATMENT OUTCOME; VASODILATATION; ADRENERGIC SYSTEM; ARTICLE; BLOOD PRESSURE; DRUG EFFECT; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; REFLEX;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; NITRENDIPINE; REFLEX; SYMPATHETIC NERVOUS SYSTEM; VASODILATION;

EID: 0031818793     PISSN: 08038023     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Opie LH. Calcium channel antagonists. IV. Side effects and contraindications drug interaction and combination. Cardiovasc Drugs Ther 1988; 2: 177-89.
2. Kleinbloesem CH, van Brummelen P, Danhlof M, Faber H, Unquhart J, Breimer DD. Rate of increase in the plasma concentration of nifedipine is a major determinant of its hemodynamic effect in humans. Clin Pharmacol Ther 1987; 41: 26-30.
3. Kiowski W, Erne P, Bertel O, Bolli P, Bühler F. Acute and chronic sympathetic reflex activation and hypertensive response to nifedipine. J Am Coll Cardiol 1986; 7: 344-8.
4. Ruzicka M, Leenen FHH. Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium antagonists. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management. 2nd ed. New York: Raven Press, 1995: 2815-25.
5. Kailasam MT, Parmer RJ, Cervenka JH, Wu RA, Ziegler MG, Kennedy BP. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension 1995; 26: 143-9.
6. Wenzel RR, Allegranza G, Binggeli C, Lüscher TF, Noll G. Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics. J Am Coll Cardiol: in press.
7. Man int Veld AJ. Calcium antagonists in hypertension. Am J Med 1989; 86: 6-14.
8. Luscher TF, Vetter H, Siegenthaler W, Vetter W. Compliance in hypertension: facts and concepts. J Hypertens 1985; 3 (Suppl 1): 3-9.
9. Kirkendall WM, Burton MC, Epstein FM, Freis ED. Recommendation for human blood pressure determination by sphyngomanometers. Circulation 1967; 36: 980-8.
10. Trimarco B, Lembo G, Ricciardelli B, et al. Salt-induced plasticity in cardiopulmonary baroreflex in salt resistent hypertensives. Hypertension 1991; 18: 483-593.
11. Trimarco B, Ricciardelli B, de Luca N, et al. Participation of endogenous cathecolamines in the regulation of left ventricular mass in progeny of hypertensive parents. Circulation 1985; 72: 38-46.
12. Devereux RB, Lutas EM, Casale PN, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurement. J Am Coll Cardiol 1984; 4: 1222-30.
13. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1997; 55: 613-8.
14. de Luca, N, Rosiello G, Lamenza F, et al. Reversal of cardiac and large arteries structural abnormalities induced by long-term antihypertensive treatment with trandolapril. Am J Cardiol 1992; 70: 52-9.
15. Trimarco B, de Luca N, De Simone A, et al. Impaired control of arginine vasopressin release by cardiopulmonary receptors in hypertensive patients with cardiac hypertrophy. Hypertension 1987; 10: 595-602.
16. Preibisz JJ, Sealey J, Aceto RM, Laragh JH. Plasma renin activity measurement: an update. Cardiovasc Rev Rep 1982; 5: 787-804.
17. Trimarco B, Lembo G, de Luca N, et al. Blunted sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy: a possible compensatory role of the atrial natriuretic factor. Circulation 1989; 80: 883-92.
18. Volpe M, Tritto C, de Luca N, et al. Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation 1993; 88: 1620-7.
19. Struyker-Boudier HAJ, De Mey JG, Smits JFM, Nievelstein HMNW. Hemodynamic action of calcium entry blockers. In: Van Zwieten PA, editor. Clinical aspects of calcium entry blockers. Progressive basic clinical pharmacology. Basel: Karger, 1989; 2: 21-66.
20. Zoller LP, Mark AL, Abboud FM, Schmid PG, Heidstad DD. The role of low-pressure baroreceptors in reflex vasoconstriction responses in man. J Clin Invest 1972; 51: 2967.
21. Johnson JM, Rowell LB, Niederberger M, Elsman MM. Human splanchnic and forearm vasoconstrictor responses to reduction of right atrial and aortic pressure. Circ Res 1974; 34: 515.
22. Abboud FM, Eckberg DL, Johanssen VJ, Mark AL. Carotid and cardiopulmonary baroreceptor control of splanchnic and forearm vascular resistance during venous pooling in man. J Physiol 1979; 286: 173.
23. Thames MD, Miller BD, Abboud FM. Sensitization of vagal cardiopulmonary baroreflex by chronic digoxin. Am J Physiol 1982; 243: H815-8.
24. Panzenbeck MJ, Tan W, Hajdu MA, et al. Prostaglandins mediate the increased sensitivity of left ventricular reflexes after treatment in conscious dogs. J Pharmacol Exp Ther 1988; 244: 384-90.
25. Ferguson DW, Hayes DW. Nifedipine potentiates cardiopulmonary baroreflex control of sympathetic nerve activity in healthy humans. Circulation 1989; 80: 285-98.
26. Inagaki O, Momose N, Nakagawa C, Honda K. Effects of YM-09730-5, a new calcium antagonist, on blood pressure and vasocontractor response in spontaneously-hypertensive rats. Jpn J Pharmacol 1987; 43: 292.